Do you have Atopic Dermatitis?
Atopic dermatitis (AD), the most common form of eczema, is a chronic inflammatory skin disorder that affects individuals of all ages, ethnicities, and geographic regions worldwide.
We are currently recruiting subjects aged 18 to 80 years with moderate to severe Atopic Dermatitis (Eczema) to take part in a research study.
Compensation for time and travel may be available. There will be no cost to you for being considered or for taking part in this study, and you will be provided with all study medication, examinations, and medical care related to the study.
Join the trial to contribute to the development of this treatment and potentially benefit from its effects.
Visites
Total
Durée
Procédures
Durée de l'étude
Total
11 to 21 visits over approximately 9 months
Durée
2 to 4 hours
Procédures
Blood samples will be collected from all participants
Durée de l'étude
Up to 4 weeks of screening period 24 weeks of treatment and approximately 8 weeks of follow up period
Résumé
This study is being done to evaluate how safe, effective, and tolerable the study drug is. The study drug is an injectable (like a shot) investigational medication known as SAR443765. If selected for the study the second part is 24 weeks of treatment where participants will have a 3 in 4 (75%) chance to receive SAR443765 and 1 in 4 (25%) chance to receive the placebo (shots with no study drug).
Problème de santé
Atopic Dermatitis (Eczema)
Traitement
SAR443765
